Source document or public record

FDA 510(k) K233100 — QIAstat-Dx® Respiratory Panel Plus

FDA 510(k) index record K233100. Device: QIAstat-Dx® Respiratory Panel Plus. Applicant as listed: QIAGEN GmbH. Decision date: 2024-05-10.

OtherU.S. Food and Drug Administration (FDA)2024-05-10

Source

"device_name": "QIAstat-Dx® Respiratory Panel Plus"

This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-20

Disclaimer

professional use

FDA 510(k) public index record K233100.

Device name: QIAstat-Dx® Respiratory Panel Plus. Applicant as listed: QIAGEN GmbH.

Decision date: 2024-05-10. Decision wording: Substantially Equivalent.

Product code: QOF. Regulation: 21 CFR 866.3981. Medical specialty: Microbiology.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.